Factors associated with COVID-19 Vaccine Hesitancy in Thai Seniors

References

• World Health Organization. WHO Coronavirus (COVID-19) DASHBOARD. Available from: https://covid19.who.int/. Accessed July 24, 2021.
   Google Scholar
• Fahriani M, Anwar S, Yufika A, et al. Disruption of childhood vaccination during the COVID-19 pandemic in Indonesia. Narra J. 2021;1(1):e7. doi:10.52225/narraj.v1i1.7
   Google Scholar
• Yusuf F, Fahriani M, Mamada SS, et al. Global prevalence of prolonged gastrointestinal symptoms in COVID-19 survivors and potential pathogenesis: a systematic review and meta-analysis. F1000Res. 2021;10:301. doi:10.12688/f1000research.52216.1
   Google Scholar
• Fahriani M, Ilmawan M, Fajar JK, et al. Persistence of long COVID symptoms in COVID-19 survivors worldwide and its potential pathogenesis - a systematic review and meta-analysis. Narra J. 2021;1(2):e36. doi:10.52225/narraj.v1i2.36
   Google Scholar
• Masyeni S, Santoso MS, Widyaningsih PD, et al. Serological cross-reaction and coinfection of dengue and COVID-19 in Asia: experience from Indonesia. Int J Infect Dis. 2021;102:152–154. doi:10.1016/j.ijid.2020.10.043
   PubMed Web of Science ®Google Scholar
• Bastola A, Sah R, Rajbhandari SK, et al. SARS-CoV-2 and orientia tsutsugamushi co-infection in a young teen, Nepal: significant burden in limited-resource countries in Asia? Narra J. 2021;1(2):e34. doi:10.52225/narraj.v1i2.34
   Google Scholar
• World Health Organization. Thailand situation. Available from: https://covid19.who.int/region/searo/country/th. Accessed July 24, 2021.
   Google Scholar
• Yanez ND, Weiss NS, Romand JA, Treggiari MM. COVID-19 mortality risk for older men and women. BMC Public Health. 2020;20(1):1742. doi:10.1186/s12889-020-09826-8
   PubMed Web of Science ®Google Scholar
• Ward H, Atchison C, Whitaker M, et al. SARS-CoV-2 antibody prevalence in England following the first peak of the pandemic. Nat Commun. 2021;12(1):905. doi:10.1038/s41467-021-21237-w
   PubMed Web of Science ®Google Scholar
• Pastor-Barriuso R, Perez-Gomez B, Hernan MA, et al. Infection fatality risk for SARS-CoV-2 in community dwelling population of Spain: nationwide seroepidemiological study. BMJ. 2020;371:m4509. doi:10.1136/bmj.m4509
   Web of Science ®Google Scholar
• O’Driscoll M, Ribeiro Dos Santos G, Wang L, et al. Age-specific mortality and immunity patterns of SARS-CoV-2. Nature. 2021;590(7844):140–145. doi:10.1038/s41586-020-2918-0
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). COVID-19 guidance for older adults. Available from: https://www.cdc.gov/aging/covid19-guidance.html. Accessed July 24, 2021.
   Google Scholar
• World Health Organization. Coronavirus disease 2019 (COVID-19) WHO Thailand situation report – 17 April 2020. Available from: https://www.who.int/docs/default-source/searo/thailand/2020-04-17-tha-sitrep-55-covid19-final.pdf?sfvrsn=c59388b9_0. Accessed July 24, 2021.
   Google Scholar
• Haas EJ, Angulo FJ, McLaughlin JM, et al. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data. Lancet. 2021;397(10287):1819–1829. doi:10.1016/S0140-6736(21)00947-8
   PubMed Web of Science ®Google Scholar
• Voysey M, Clemens SAC, Madhi SA, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021;397(10269):99–111. doi:10.1016/S0140-6736(20)32661-1
   PubMed Web of Science ®Google Scholar
• Jara A, Undurraga EA, Gonzalez C, et al. Effectiveness of an inactivated SARS-CoV-2 vaccine in Chile. N Engl J Med. 2021;385(10):875–884. doi:10.1056/NEJMoa2107715
   PubMed Web of Science ®Google Scholar
• Strategic Advisory Group of Experts (SAGE) on Immunization. Report of the SAGE working group on vaccine hesitancy. Available from: https://www.who.int/immunization/sage/meetings/2014/october/1_Report_WORKING_GROUP_vaccine_hesitancy_final.pdf. Accessed July 24, 2021.
   Google Scholar
• MacDonald NE. Hesitancy SWGoV. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33(34):4161–4164. doi:10.1016/j.vaccine.2015.04.036
   PubMed Web of Science ®Google Scholar
• Robinson E, Jones A, Lesser I, Daly M. International estimates of intended uptake and refusal of COVID-19 vaccines: a rapid systematic review and meta-analysis of large nationally representative samples. Vaccine. 2021;39(15):2024–2034. doi:10.1016/j.vaccine.2021.02.005
   PubMed Web of Science ®Google Scholar
• World Medical Association. World Medical Association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191–2494. doi:10.1001/jama.2013.281053
   PubMed Web of Science ®Google Scholar
• World Medical Association. WMA declaration of Helsinki - ethical principles for medical research involving human subjects. Available from: https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/. Accessed August 1, 2021.
   Google Scholar
• Robertson E, Reeve KS, Niedzwiedz CL, et al. Predictors of COVID-19 vaccine hesitancy in the UK household longitudinal study. Brain Behav Immun. 2021;94:41–50. doi:10.1016/j.bbi.2021.03.008
   PubMed Web of Science ®Google Scholar
• Lin C, Tu P, Beitsch LM. Confidence and receptivity for COVID-19 vaccines: a rapid systematic review. Vaccines. 2020;9(1):16. doi:10.3390/vaccines9010016
   PubMed Web of Science ®Google Scholar
• Okubo R, Yoshioka T, Ohfuji S, Matsuo T, Tabuchi T. COVID-19 vaccine hesitancy and its associated factors in Japan. Vaccines. 2021;9(6):662. doi:10.3390/vaccines9060662
   PubMed Web of Science ®Google Scholar
• Soares P, Rocha JV, Moniz M, et al. Factors associated with COVID-19 vaccine hesitancy. Vaccines. 2021;9(3):300. doi:10.3390/vaccines9030300
   Web of Science ®Google Scholar
• Fridman A, Gershon R, Gneezy A, Capraro V. COVID-19 and vaccine hesitancy: a longitudinal study. PLoS One. 2021;16(4):e0250123. doi:10.1371/journal.pone.0250123
   PubMed Web of Science ®Google Scholar
• Kreps S, Prasad S, Brownstein JS, et al. Factors associated with US adults’ likelihood of accepting COVID-19 vaccination. JAMA Netw Open. 2020;3(10):e2025594. doi:10.1001/jamanetworkopen.2020.25594
   PubMed Web of Science ®Google Scholar
• Kelly BJ, Southwell BG, McCormack LA, et al. Predictors of willingness to get a COVID-19 vaccine in the U.S. BMC Infect Dis. 2021;21(1):338. doi:10.1186/s12879-021-06023-9
   PubMed Web of Science ®Google Scholar
• Syed Alwi SAR, Rafidah E, Zurraini A, Juslina O, Brohi IB, Lukas S. A survey on COVID-19 vaccine acceptance and concern among Malaysians. BMC Public Health. 2021;21(1):1129. doi:10.1186/s12889-021-11071-6
   PubMed Web of Science ®Google Scholar
• Daly M, Robinson E. Willingness to vaccinate against COVID-19 in the U.S.: representative longitudinal evidence from April to October 2020. Am J Prev Med. 2021;60(6):766–773. doi:10.1016/j.amepre.2021.01.008
   PubMed Web of Science ®Google Scholar
• Loomba S, de Figueiredo A, Piatek SJ, de Graaf K, Larson HJ. Measuring the impact of COVID-19 vaccine misinformation on vaccination intent in the UK and USA. Nat Hum Behav. 2021;5(3):337–348. doi:10.1038/s41562-021-01056-1
   PubMed Web of Science ®Google Scholar
• Callaghan T, Moghtaderi A, Lueck JA, et al. Correlates and disparities of intention to vaccinate against COVID-19. Soc Sci Med. 2021;272:113638. doi:10.1016/j.socscimed.2020.113638
   PubMed Web of Science ®Google Scholar
• Wang J, Jing R, Lai X, et al. Acceptance of COVID-19 vaccination during the COVID-19 pandemic in China. Vaccines. 2020;8(3):482. doi:10.3390/vaccines8030482
   PubMed Web of Science ®Google Scholar
• Ward JK, Alleaume C, Peretti-Watel P, Group C. The French public’s attitudes to a future COVID-19 vaccine: the politicization of a public health issue. Soc Sci Med. 2020;265:113414. doi:10.1016/j.socscimed.2020.113414
   PubMed Web of Science ®Google Scholar
• World Health Organization. Coronavirus disease 2019 (COVID-19) WHO Thailand situation report – 22 July 2021. Available from: https://cdn.who.int/media/docs/default-source/searo/thailand/2021_07_22_eng-sitrep-193-covid19.pdf?sfvrsn=a0fdd5a7_3. Accessed August 1, 2021.
   Google Scholar
• World Health Organization. WHO Coronavirus (COVID-19) dashboard (Thailand). Available from: https://covid19.who.int/region/searo/country/th. Accessed August 1, 2021.
   Google Scholar
• Neumann-Bohme S, Varghese NE, Sabat I, et al. Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19. Eur J Health Econ. 2020;21(7):977–982. doi:10.1007/s10198-020-01208-6
   PubMed Web of Science ®Google Scholar
• Al-Mohaithef M, Padhi BK. Determinants of COVID-19 vaccine acceptance in Saudi Arabia: a web-based national survey. J Multidiscip Healthc. 2020;13:1657–1663. doi:10.2147/JMDH.S276771
   PubMed Web of Science ®Google Scholar
• Yoda T, Katsuyama H. Willingness to receive COVID-19 vaccination in Japan. Vaccines. 2021;9(1):48. doi:10.3390/vaccines9010048
   PubMed Web of Science ®Google Scholar
• Williams L, Flowers P, McLeod J, Young D, Rollins L; The Catalyst Project T. Social patterning and stability of intention to accept a COVID-19 vaccine in Scotland: will those most at risk accept a vaccine? Vaccines. 2021;9(1):48. doi:10.3390/vaccines9010017
   Web of Science ®Google Scholar
• Fisher KA, Bloomstone SJ, Walder J, Crawford S, Fouayzi H, Mazor KM. Attitudes toward a potential SARS-CoV-2 vaccine: a survey of U.S. adults. Ann Intern Med. 2020;173(12):964–973. doi:10.7326/M20-3569
   PubMed Web of Science ®Google Scholar
• Reiter PL, Pennell ML, Katz ML. Acceptability of a COVID-19 vaccine among adults in the United States: how many people would get vaccinated? Vaccine. 2020;38(42):6500–6507. doi:10.1016/j.vaccine.2020.08.043
   PubMed Web of Science ®Google Scholar
• Lopez Bernal J, Andrews N, Gower C, et al. Effectiveness of COVID-19 vaccines against the B.1.617.2 (delta) variant. N Engl J Med. 2021;385(7):585–594. doi:10.1056/NEJMoa2108891
   PubMed Web of Science ®Google Scholar
• Han MFY, Mahendran R, Yu J. Associations between fear of COVID-19, affective symptoms and risk perception among community-dwelling older adults during a COVID-19 lockdown. Front Psychol. 2021;12:638831. doi:10.3389/fpsyg.2021.638831
   PubMed Web of Science ®Google Scholar